NRXPW logo

NRx Pharmaceuticals (NRXPW) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

01 December 2017

Indexes:

Not included

Description:

NRx Pharmaceuticals focuses on developing innovative treatments for central nervous system disorders and other serious conditions. The company aims to address unmet medical needs through advanced research and clinical trials, particularly in areas like depression and neurodegenerative diseases.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

25 May '23 HC Wainwright & Co.
Buy
02 Feb '23 HC Wainwright & Co.
Buy
09 Nov '22 Ascendiant Capital
Buy
30 June '22 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of NRx Pharmaceuticals?
  • What is the ticker symbol for NRx Pharmaceuticals?
  • Does NRx Pharmaceuticals pay dividends?
  • What sector is NRx Pharmaceuticals in?
  • What industry is NRx Pharmaceuticals in?
  • What country is NRx Pharmaceuticals based in?
  • When did NRx Pharmaceuticals go public?
  • Is NRx Pharmaceuticals in the S&P 500?
  • Is NRx Pharmaceuticals in the NASDAQ 100?
  • Is NRx Pharmaceuticals in the Dow Jones?
  • When does NRx Pharmaceuticals report earnings?

What is the primary business of NRx Pharmaceuticals?

NRx Pharmaceuticals focuses on developing innovative treatments for central nervous system disorders and other serious conditions. The company aims to address unmet medical needs through advanced research and clinical trials, particularly in areas like depression and neurodegenerative diseases.

What is the ticker symbol for NRx Pharmaceuticals?

The ticker symbol for NRx Pharmaceuticals is NASDAQ:NRXPW

Does NRx Pharmaceuticals pay dividends?

No, NRx Pharmaceuticals does not pay dividends

What sector is NRx Pharmaceuticals in?

NRx Pharmaceuticals is in the Healthcare sector

What industry is NRx Pharmaceuticals in?

NRx Pharmaceuticals is in the Biotechnology industry

What country is NRx Pharmaceuticals based in?

NRx Pharmaceuticals is headquartered in United States

When did NRx Pharmaceuticals go public?

NRx Pharmaceuticals's initial public offering (IPO) was on 01 December 2017

Is NRx Pharmaceuticals in the S&P 500?

No, NRx Pharmaceuticals is not included in the S&P 500 index

Is NRx Pharmaceuticals in the NASDAQ 100?

No, NRx Pharmaceuticals is not included in the NASDAQ 100 index

Is NRx Pharmaceuticals in the Dow Jones?

No, NRx Pharmaceuticals is not included in the Dow Jones index

When does NRx Pharmaceuticals report earnings?

The date for NRx Pharmaceuticals's next earnings report has not been announced yet